{"id":"https://openalex.org/W2003454794","doi":"https://doi.org/10.1001/jama.1964.03060340053017","title":"Angiothrombotic Pulmonary Hypertension in Addicts","display_name":"Angiothrombotic Pulmonary Hypertension in Addicts","publication_year":1964,"publication_date":"1964-05-25","ids":{"openalex":"https://openalex.org/W2003454794","doi":"https://doi.org/10.1001/jama.1964.03060340053017","mag":"2003454794","pmid":"https://pubmed.ncbi.nlm.nih.gov/14122687"},"language":"en","primary_location":{"id":"doi:10.1001/jama.1964.03060340053017","doi":"https://doi.org/10.1001/jama.1964.03060340053017","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.1964.03060340053017","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000203715","display_name":"Vernon E. Wendt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vernon E. Wendt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014591068","display_name":"Henry E. Puro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry E. Puro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055467861","display_name":"Jack Shapiro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jack Shapiro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"William Mathews","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Mathews","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000100679","display_name":"Paul L. Wolf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul L. Wolf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.7904,"has_fulltext":false,"cited_by_count":78,"citation_normalized_percentile":{"value":0.96992481,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"188","issue":"8","first_page":"755","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12199","display_name":"Vascular Anomalies and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/substance-use-disorders","display_name":"substance use disorders","score":0.5440000295639038},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.5350000262260437},{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibitors","display_name":"monoamine oxidase inhibitors","score":0.6919999718666077},{"id":"https://openalex.org/keywords/pargyline","display_name":"pargyline","score":0.8980000019073486},{"id":"https://openalex.org/keywords/tyramine","display_name":"tyramine","score":0.671999990940094},{"id":"https://openalex.org/keywords/catecholamine-release","display_name":"catecholamine release","score":0.6890000104904175},{"id":"https://openalex.org/keywords/metanephrine","display_name":"metanephrine","score":0.8019999861717224},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.8339999914169312}],"concepts":[{"id":"https://openalex.org/C2779505177","wikidata":"https://www.wikidata.org/wiki/Q517109","display_name":"Normetanephrine","level":3,"score":0.9143562316894531},{"id":"https://openalex.org/C2776077682","wikidata":"https://www.wikidata.org/wiki/Q165930","display_name":"Tyramine","level":2,"score":0.8887413740158081},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8031713962554932},{"id":"https://openalex.org/C2776783082","wikidata":"https://www.wikidata.org/wiki/Q412766","display_name":"Metanephrine","level":3,"score":0.7872174978256226},{"id":"https://openalex.org/C2778575451","wikidata":"https://www.wikidata.org/wiki/Q421368","display_name":"Iproniazid","level":4,"score":0.7321815490722656},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.6766440868377686},{"id":"https://openalex.org/C2777067607","wikidata":"https://www.wikidata.org/wiki/Q781329","display_name":"Pargyline","level":4,"score":0.6512526273727417},{"id":"https://openalex.org/C2775859304","wikidata":"https://www.wikidata.org/wiki/Q132621","display_name":"Epinephrine","level":2,"score":0.6167117953300476},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6103575229644775},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5773694515228271},{"id":"https://openalex.org/C2776460385","wikidata":"https://www.wikidata.org/wiki/Q420060","display_name":"Hydrochloride","level":2,"score":0.5593530535697937},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4578091502189636},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.4238210618495941},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.39849674701690674},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.3720666170120239},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36927467584609985},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3591189384460449},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.19588220119476318},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1639755368232727},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.11362722516059875},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D004696","descriptor_name":"Endocarditis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004697","descriptor_name":"Endocarditis, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006976","descriptor_name":"Hypertension, Pulmonary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009892","descriptor_name":"Opium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010336","descriptor_name":"Pathology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011655","descriptor_name":"Pulmonary Embolism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014116","descriptor_name":"Toxicology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014309","descriptor_name":"Tripelennamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/jama.1964.03060340053017","doi":"https://doi.org/10.1001/jama.1964.03060340053017","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.1964.03060340053017","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},{"id":"pmid:14122687","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14122687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1538208399","https://openalex.org/W1985473738","https://openalex.org/W2005053169"],"related_works":["https://openalex.org/W1975829463","https://openalex.org/W1965146705","https://openalex.org/W2150033170","https://openalex.org/W2073455958","https://openalex.org/W4415585264","https://openalex.org/W2465197443","https://openalex.org/W4254026138","https://openalex.org/W1878273062","https://openalex.org/W2616111114","https://openalex.org/W4246557371"],"abstract_inverted_index":{"MAO":[0,25,104,113],"is":[1,28,32,101,110],"one":[2],"of":[3,10,24,38,59,79,133],"the":[4,8,22,57,96],"enzymes":[5],"involved":[6],"in":[7,35,76,92],"metabolism":[9],"potent":[11,120],"biogenic":[12],"amines":[13],"such":[14],"as":[15,45,74,95,119,121,142],"l-epinephrine,":[16],"l-norepinephrine,":[17],"serotonin,":[18],"tyramine,":[19],"and":[20,40],"dopamine.4After":[21],"administration":[23,132],"inhibitors,":[26],"it":[27,54],"believed":[29],"that":[30],"there":[31],"an":[33,124,143],"increase":[34],"tissue":[36],"levels":[37],"l-epinephrine":[39],"l-norepinephrine.":[41],"Tyramine":[42],"may":[43,55],"act":[44],"a":[46,111,134],"pressor":[47],"substance":[48],"normally":[49],"degraded":[50],"by":[51],"MAO,":[52],"or":[53,86],"provoke":[56],"release":[58],"stored":[60],"catechol":[61],"amines.5As":[62],"contrasted":[63],"with":[64,123],"pheochromocytoma,":[65],"urinary":[66],"3-methoxy,":[67,97],"4-hydroxymandelic":[68,98],"acid":[69,99],"determinations":[70],"have":[71],"been":[72],"reported":[73],"normal":[75],"those":[77],"cases":[78],"cheese-induced":[80],"hypertension":[81],"so":[82],"studied.":[83],"Perhaps":[84],"metanephrine":[85],"normetanephrine":[87],"output":[88],"must":[89],"be":[90],"measured":[91],"this":[93],"situation,":[94],"pathway":[100],"dependent":[102],"on":[103],"activity.":[105],"Pargyline":[106],"hydrochloride":[107],"(N-benzyl-N-methyl-2-propynylamine":[108],"hydrochloride)":[109],"nonhydrazine":[112],"inhibitor":[114],"seven":[115],"to":[116,128],"ten":[117,129],"times":[118],"iproniazid,":[122],"effect":[125],"lasting":[126],"up":[127],"days":[130],"after":[131],"single":[135],"oral":[136],"dose.":[137],"This":[138],"drug":[139],"was":[140],"evaluated":[141],"antihypertensive":[144],"agent":[145]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}